semaglutide and nafld Phase 3 Trial of in Metabolic Dysfunction–Associated Steatohepatitis Semaglutide Showing Promise in Treating

The tradeoff: more receptor targets mean more potential side effects

Eating intentionally, with a focus on protein, produces dramatically different results than eating reactively, or not eating at all

"Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist medication that is used for the treatment of obesity and Type 2 diabetes," she says

Targeted exercises strengthen weak muscles and stretch tight ones to restore proper neck mechanics

In a world of quick 2 minute appointments in offices where you feel like a number, this was not that

A simple way to understand it: Semaglutide = GLP-1 receptor agonist Tirzepatide = GIP + GLP-1 dual agonist Retatrutide = GIP + GLP-1 + glucagon triple agonist That difference makes retatrutide vs semaglutide and tirzepatide an important topic for patients who follow new weight loss treatments